| Name | Title | Contact Details |
|---|
Snapdocs powers homeownership. Using technology, we`re building the connective tissue for an entire pillar of the U.S. economy: residential real estate. Today, we`re working to perfect mortgage closings, but that`s only the beginning. If we succeed, more than five million families per year will gain clarity and transparency as they make the biggest financial decision of their lives: buying a home. Before Snapdocs, no one felt responsible or empowered to solve the problems we face every day we come to the office. It`s complex and difficult work, and the result is not an app we brag about at tech industry parties. Instead, we`re making a difference and carefully building a team that shares our priorities—pragmatism, respect and empathy for our clients, and building honest products that improve all our users` lives.
Bill Schrink is a Redwood City, CA-based company in the Software and Internet sector.
Formula Travel Solutions is a Greenfield, IN-based company in the Software and Internet sector.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.